In an attempt to ascertain the mechanism of platinum resistance in patients with hepatocellular carcinoma, researchers observed an enhanced degree of resistance to cisplatin-induced cell death in ANXA3-overexpressing tumor cells in vitro and in engrafted mice in vivo (Pan et al., 2015b). Here, ANXA3 is linked to hepatocellular carcinoma.